The investigators have greatly improved these models to recapitulate better the complicated pathophysiological mechanism of DUX4 activity and the phenotypic features seen in FSHD patients (32,71); nonetheless, a standard model of the disease has not been decided yet. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.